Ammonium lactate and Celebrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ammonium lactate (ammonium lactate) and Celebrex (celecoxib). Common drug interactions include chronic kidney disease among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Ammonium lactate and Celebrex. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Ammonium lactate?

Ammonium lactate has active ingredients of ammonium lactate. eHealthMe is studying from 2,151 Ammonium lactate users. Check the latest studies of Ammonium lactate.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.



On Jul, 09, 2026

33 people who take Ammonium lactate and Celebrex together, and have interactions are studied.

Ammonium lactate and Celebrex drug interactions.

What are the common drug interactions of Ammonium Lactate and Celebrex, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal impairment (severely reduced kidney function)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Constipation
  7. Decreased activity
  8. Depression
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  10. Emotional distress

male:

  1. Abdominal pain
  2. Agitation (state of anxiety or nervous excitement)
  3. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  4. Dizziness
  5. Drug hypersensitivity
  6. Dyspepsia (indigestion)
  7. Feeling hot
  8. Feeling of body temperature change
  9. Heart rate decreased
  10. Hypoglycaemia (deficiency of glucose in the bloodstream)

What are the common drug interactions of Ammonium Lactate and Celebrex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Decreased activity
  5. Depression
  6. Emotional distress
  7. Renal failure (kidney dysfunction)
  8. Renal impairment (severely reduced kidney function)
  9. Upper respiratory tract infection

50-59:

  1. Chronic kidney disease
  2. Constipation
  3. Muscular weakness (muscle weakness)
  4. Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
  5. Renal failure (kidney dysfunction)
  6. Stomatitis (inflammation of mucous membrane of mouth)
  7. Vision blurred
  8. Adverse event
  9. Conjunctivitis (pink eye)
  10. Gastric ulcer (stomach ulcer)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Abdominal pain
  4. Agitation (state of anxiety or nervous excitement)
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Blood creatine increased
  8. Blood pressure increased
  9. Breast disorder
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Pain: 12 people, 36.36%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 36.36%
  3. High Blood Pressure: 10 people, 30.30%
  4. High Blood Cholesterol: 10 people, 30.30%
  5. Diabetes: 7 people, 21.21%
  6. Neuralgia (pain in one or more nerves): 7 people, 21.21%
  7. Dry Skin: 6 people, 18.18%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 15.15%
  9. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 4 people, 12.12%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take Ammonium lactate and Celebrex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ammonium lactate and Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ammonium lactate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ammonium lactate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celebrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ammonium lactate and celecoxib (the active ingredients of Ammonium lactate and Celebrex, respectively), and Ammonium lactate and Celebrex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: